IRGC’s Noura COVID-19 Vaccine Completes 1st Phase of Clinical Trials

The commander of Iran’s Islamic Revolution Guards Corps says the coronavirus vaccine the force is developing has successfully passed the first phase of clinical trials.

“This vaccine was successful in the first phase of clinical trials and we have entered the second phase of the trials,” said Major General Hossein Salami, on the sidelines of a visit to a hospital in the southern city of Kerman, where Covid patients are receiving care.

“The Health Ministry is closely overseeing the production process of the vaccines by experts at [IRGC’s] Baqiyatallah University of Medical Sciences. The production of the vaccine is going through its normal process and, God willing, the vaccine will reach its final phase in the next few months.”

The IRGC unveiled its coronavirus vaccine dubbed Noora in late June and the clinical trials began immediately afterward. Noura is one of the eight Covid-19 vaccines being developed inside Iran.

Subscribe
The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.

LEAVE A REPLY

Please enter your comment!
Please enter your name here